Strasbourg Oncologie Libérale

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Karim Fizazi, Stéphanie Foulon, Joan Carles et al. · The Lancet · 2022 · 783 citations · Full text

Medicine, Oncology, Urology +17

Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial

Antonio González-Martı́n, Christophe Desauw, Florian Heitz et al. · European Journal of Cancer · 2022 · 72 citations · Full text

Medicine, Oncology, Pharmacology +16

Polymorphisms of the β2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies

Stefan-Martin Herrmann, Viviane Nicaud, Laurence Tiret et al. · Journal of Hypertension · 2002 · 69 citations

Medicine, Genetics, Molecular Genetics +14

Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE

Pierre‐Yves Benhamou, Bogdan Catargi, B. Delenne et al. · Diabetes & Metabolism · 2012 · 42 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

Giulia Baciarello, R. Delva, Gwénaëlle Gravis et al. · European Urology · 2021 · 40 citations

Medicine, Oncology, Pharmacology +15